» Articles » PMID: 17363620

From T-tubule to Sarcolemma: Damage-induced Dysferlin Translocation in Early Myogenesis

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2007 Mar 17
PMID 17363620
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The dysferlin gene is mutated in limb-girdle muscular dystrophy type 2B, Miyoshi myopathy, and distal anterior compartment myopathy. In mature skeletal muscle, dysferlin is located predominantly at the sarcolemma, where it plays a role in membrane fusion and repair. To investigate the role of dysferlin during early muscle differentiation, its localization was studied at high resolution in a muscle cell line. This demonstrated that dysferlin is not expressed at the plasmalemma of myotubes but mostly localizes to the T-tubule network. However, dysferlin translocated to the site of injury and toward the plasma membrane in a Ca2+-dependent fashion in response to a newly designed in vitro wounding assay. This reaction was specific to the full-length protein, as heterologously expressed deletion mutants of distinct C2 domains of dysferlin did not show this response. These results shed light on the dynamics of muscle membrane repair and are highly indicative of a specific role of dysferlin in this process in early myogenesis.

Citing Articles

Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells.

Anwar S, Roshmi R, Woo S, Haque U, Arthur Lee J, Duddy W Mol Ther Nucleic Acids. 2025; 36(1):102443.

PMID: 39967852 PMC: 11834094. DOI: 10.1016/j.omtn.2024.102443.


Analysis of Exon Skipping Applicability for Dysferlinopathies.

Leckie J, Rodriguez S, Krahn M, Yokota T Cells. 2025; 14(3).

PMID: 39936969 PMC: 11817064. DOI: 10.3390/cells14030177.


Cryo-EM structures of the membrane repair protein dysferlin.

Huang H, Grandinetti G, Heissler S, Chinthalapudi K Nat Commun. 2024; 15(1):9650.

PMID: 39511170 PMC: 11544258. DOI: 10.1038/s41467-024-53773-6.


Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expression.

Bulgart H, Lopez Perez M, Tucker A, Giarrano G, Banford K, Miller O FASEB J. 2024; 38(20):e70099.

PMID: 39400395 PMC: 11486262. DOI: 10.1096/fj.202401731RR.


The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.

Anwar S, Yokota T Biomolecules. 2024; 14(3).

PMID: 38540676 PMC: 10968265. DOI: 10.3390/biom14030256.